autoimmune hematocytopenias often require long-term immunosuppressive therapy to manage symptoms effectively.
自身免疫性细胞减少症通常需要长期使用免疫抑制治疗以有效控制症状。
severe hematocytopenias can significantly increase the risk of life-threatening infections and bleeding complications.
重度细胞减少症会显著增加发生危及生命的感染和出血并发症的风险。
drug-induced hematocytopenias typically resolve completely after discontinuation of the offending medication.
药物引起的细胞减少症通常在停用有问题的药物后完全消失。
peripheral hematocytopenias differ significantly from central forms in their underlying pathophysiology and treatment approaches.
周围细胞减少症在潜在的病理生理机制和治疗方法上与中心形式有显着差异。
congenital hematocytopenias are rare genetic disorders that typically present with symptoms during early childhood development.
先天性细胞减少症是罕见的遗传性疾病，通常在幼儿发育期间出现症状。
chronic hematocytopenias may lead to adaptive changes in bone marrow function over extended periods of time.
慢性细胞减少症可能导致骨髓功能在一段时间内发生适应性变化。
the patient was diagnosed with idiopathic hematocytopenias after exhaustive diagnostic evaluation revealed no underlying cause.
在进行了详尽的诊断评估后，患者被诊断出患有特发性细胞减少症，未发现任何潜在原因。
inherited hematocytopenias often involve specific mutations affecting normal hematopoietic stem cell development and function.
遗传性细胞减少症通常涉及影响正常造血干细胞发育和功能的特定突变。
pregnancy can markedly exacerbate pre-existing hematocytopenias, requiring careful monitoring throughout all trimesters.
妊娠会显著加重已有的细胞减少症，需要在整个妊娠期进行仔细监测。
secondary hematocytopenias frequently arise from underlying systemic diseases, malignancies, or severe nutritional deficiencies.
继发性细胞减少症通常源于潜在的系统性疾病、恶性肿瘤或严重的营养不良。
mild hematocytopenias often remain completely asymptomatic and are discovered incidentally during routine blood examinations.
轻度细胞减少症通常完全没有症状，并且在常规血液检查中偶然发现。
hematocytopenias in elderly patients present unique diagnostic challenges and often require modified therapeutic approaches.
老年患者的细胞减少症提出了独特的诊断挑战，并且通常需要修改治疗方法。
autoimmune hematocytopenias often require long-term immunosuppressive therapy to manage symptoms effectively.
自身免疫性细胞减少症通常需要长期使用免疫抑制治疗以有效控制症状。
severe hematocytopenias can significantly increase the risk of life-threatening infections and bleeding complications.
重度细胞减少症会显著增加发生危及生命的感染和出血并发症的风险。
drug-induced hematocytopenias typically resolve completely after discontinuation of the offending medication.
药物引起的细胞减少症通常在停用有问题的药物后完全消失。
peripheral hematocytopenias differ significantly from central forms in their underlying pathophysiology and treatment approaches.
周围细胞减少症在潜在的病理生理机制和治疗方法上与中心形式有显着差异。
congenital hematocytopenias are rare genetic disorders that typically present with symptoms during early childhood development.
先天性细胞减少症是罕见的遗传性疾病，通常在幼儿发育期间出现症状。
chronic hematocytopenias may lead to adaptive changes in bone marrow function over extended periods of time.
慢性细胞减少症可能导致骨髓功能在一段时间内发生适应性变化。
the patient was diagnosed with idiopathic hematocytopenias after exhaustive diagnostic evaluation revealed no underlying cause.
在进行了详尽的诊断评估后，患者被诊断出患有特发性细胞减少症，未发现任何潜在原因。
inherited hematocytopenias often involve specific mutations affecting normal hematopoietic stem cell development and function.
遗传性细胞减少症通常涉及影响正常造血干细胞发育和功能的特定突变。
pregnancy can markedly exacerbate pre-existing hematocytopenias, requiring careful monitoring throughout all trimesters.
妊娠会显著加重已有的细胞减少症，需要在整个妊娠期进行仔细监测。
secondary hematocytopenias frequently arise from underlying systemic diseases, malignancies, or severe nutritional deficiencies.
继发性细胞减少症通常源于潜在的系统性疾病、恶性肿瘤或严重的营养不良。
mild hematocytopenias often remain completely asymptomatic and are discovered incidentally during routine blood examinations.
轻度细胞减少症通常完全没有症状，并且在常规血液检查中偶然发现。
hematocytopenias in elderly patients present unique diagnostic challenges and often require modified therapeutic approaches.
老年患者的细胞减少症提出了独特的诊断挑战，并且通常需要修改治疗方法。
探索常用高频词汇